Abvc Biopharma Rises On Unit's Tie: up with MerDury BioPharma

ABVC Biopharma

06/06/2023 17:54

** Shares of drug developer ABVC BioPharma Inc  ABVC.O  rise
 3% to 63 cents
    ** Co says its subsidiary BioKey signed an agreement with
MerDury BioPharma to co-develop new drug products using
MerDury's StackDose platform technology
    ** The platform has the technology to generate new products
with fat release properties when it is administered orally and
performs an automatic 3D printing manufacturing process
     ** The tech will enable co to develop more IP-protected and
brand-name products for commercialization - ABVC
    ** Stock down ~1% YTD

 (Reporting by Sriparna Roy in Bengaluru)
 ((Sriparna.Roy@thomsonreuters.com;))